Hip surgery pain relief: less may be more?
NCT ID NCT07023120
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how much numbing medicine (ropivacaine) and whether adding dexamethasone affects pain control after hip replacement. 120 adults were split into four groups, each getting a different combination. The goal was to see which approach delays the need for strong painkillers and reduces overall opioid use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ropivacaine and dexamethasone
- What this could lead to
- If successful, this could lead to better pain relief and less opioid use after hip replacement surgery.
- What could go wrong
- This is a small, completed Phase 4 trial. The results may not apply to all patients or surgeries, and the best dose may still need more testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Poznan University of Medical Sciences
Poznan, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do screws make hip replacements last longer?
- Ceramic hip resurfacing: a Metal-Free future for joint replacement?
- Can a less invasive hip surgery speed up recovery?
- Can a diabetes drug improve joint replacement outcomes?
- Can a sedative calm the Body's surgical storm?
- Virtual reality could replace sedatives for anxious hip surgery patients